TESTOSTERONE

Post-LOE

testosterone

Design Pharmaceuticals

ANDATRANSDERMALGEL

Approved

Jul 2017

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

TESTOSTERONE (testosterone) by Design Pharmaceuticals is androgen receptor agonists [moa]. Approved for androgen [epc]. First approved in 2017.

Drug data last refreshed 18h ago

Mechanism of Action

Androgen Receptor Agonists

Pharmacologic Class:

Androgen

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (20)

NCT04601233Phase 4Not Yet Recruiting

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Started Jun 2026

20 enrolled

Multiple SclerosisErectile DysfunctionTestosterone Deficiency

NCT07142551Phase 2Recruiting

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Started Mar 2026

60 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT07227740N/ARecruiting

Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury

Started Jul 2025

48 enrolled

Spinal Cord InjuriesEndothelial DysfunctionTestosterone Deficiency

NCT06689085Phase 3Recruiting

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Started Mar 2025

100 enrolled

Hypogonadism, Male

NCT06670053N/ARecruiting

Puberty, Testosterone, and Brain Development

Started Dec 2024

100 enrolled

Gender IdentityGender Dysphoria in Adolescents and AdultsHeadache+1 more

Worked on TESTOSTERONE at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.